Literature DB >> 641141

The key role of peptidoglycan in the opsonization of Staphylococcus aureus.

P K Peterson, B J Wilkinson, Y Kim, D Schmeling, S D Douglas, P G Quie, J Verhoef.   

Abstract

In an effort to determine the staphylococcal cell surface component(s) of importance in opsonization, cell walls (peptidoglycan and teichoic acid) and peptidoglycan were isolated from Staphylococcus aureus strain H grown in [3H]glycine-containing broth. After incubation of the cell walls and peptidoglycan with various opsonic sources, uptake by human polymorphonuclear leukocytes was measured. The opsonic requirements for phagocytosis of cell walls and peptidoglycan were found to be similar to those of intact bacteria. Removal of teichoic acid from the cell wall did not affect opsonization. Likewise, a teichoic acid-deficient mutant strain of S. aureus H was opsonized in a manner similar to that of the parent strain. Immunoglobulin G functioned as the major heat-stable opsonic factor and both the classical and alternative pathways participated in opsonization. Kinetic studies revealed that opsonization of peptidoglycan, as well as C3-C9 consumption by peptidoglycan, proceeded at a slower rate via the alternative pathway (C2-deficient serum) than when the classical pathway was present (normal serum). The ability of peptidoglycan to activate C3-C9 was significantly reduced when normal and C2-deficient sera were preabsorbed with peptidoglycan at 2 degrees C suggesting that antibodies to peptidoglycan may be involved in activation of both the classical and alternative complement pathways. Thus, peptidoglycan appears to be the key cell wall component involved in staphylococcal opsonization, and it is suggested that host response to peptidoglycan, a major cell wall component of most gram-positive bacteria, may be related to the development of "natural immunity" to this group of microorganisms.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 641141      PMCID: PMC372572          DOI: 10.1172/JCI108971

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  Interaction of peptidoglycans with anti-IgGs and with complement.

Authors:  V A Bokisch
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1975-07

2.  Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.

Authors:  J Verhoef; P Peterson; Y Kim; L D Sabath; P G Quie
Journal:  Immunology       Date:  1977-08       Impact factor: 7.397

3.  Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS).

Authors:  D C Morrison; L F Kline
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

Review 4.  Lipoteichoic acids: a new class of bacterial antigen.

Authors:  A J Wicken; K W Knox
Journal:  Science       Date:  1975-03-28       Impact factor: 47.728

5.  Human polymorphonuclear leucocyte receptors for staphylococcal opsonins.

Authors:  J Verhoef; P K Peterson; P G Quie
Journal:  Immunology       Date:  1977-08       Impact factor: 7.397

6.  Detection of antibodies to bacterial cell wall peptidoglycan in human sera.

Authors:  B Heymer; K H Schleifer; S Read; J B Zabriskie; R M Krause
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

7.  Cell-mediated immune reactions in vitro to cell walls and peptidoglycan from Staphylococcus aureus.

Authors:  S P Targowski; D T Berman
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1975-07

8.  Studies on the linkage between teichoic acid and peptidoglycan in a bacteriophage-resistant mutant of Staphylococcus aureus H.

Authors:  J E Heckels; A R Archibald; J Baddiley
Journal:  Biochem J       Date:  1975-09       Impact factor: 3.857

9.  An electron microscopic study of the location of teichoic acid and its contribution to staining reactions in walls of Streptococcus faecalis 8191.

Authors:  J M Garland; A R Archibald; J Baddiley
Journal:  J Gen Microbiol       Date:  1975-07

10.  Recurrence of membranoproliferative glomerulonephritis following kidney transplantation. Serum complement component studies.

Authors:  R H McLean; H Geiger; B Burke; R Simmons; J Najarian; R L Vernier; A F Michael
Journal:  Am J Med       Date:  1976-01       Impact factor: 4.965

View more
  66 in total

1.  The macrophage response to bacteria. Modulation of macrophage functional activity by peptidoglycan from Moraxella (Branhamella) catarrhalis.

Authors:  R Keller; J E Gustafson; R Keist
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

2.  Staphylococcus aureus cell surface: capsule as a barrier to bacteriophage adsorption.

Authors:  B J Wilkinson; K M Holmes
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

3.  Exposure of Staphylococcus aureus to Targocil Blocks Translocation of the Major Autolysin Atl across the Membrane, Resulting in a Significant Decrease in Autolysis.

Authors:  Kiran B Tiwari; Craig Gatto; Suzanne Walker; Brian J Wilkinson
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

4.  Antibody response to teichoic acid and peptidoglycan in Staphylococcus aureus osteomyelitis.

Authors:  E Jacob; L C Durham; M C Falk; T J Williams; L J Wheat
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

5.  Interleukin-8 gene expression in Staphylococcus aureus-infected endothelial cells.

Authors:  L Yao; F D Lowy; J W Berman
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

6.  Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients.

Authors:  Agnieszka Dryla; Sonja Prustomersky; Dieter Gelbmann; Markus Hanner; Edith Bettinger; Béla Kocsis; Tamás Kustos; Tamás Henics; Andreas Meinke; Eszter Nagy
Journal:  Clin Diagn Lab Immunol       Date:  2005-03

7.  Immunochemical study of diverse surface antigens of a Staphylococcus aureus isolate from an osteomyelitis patient and their role in in vitro phagocytosis.

Authors:  W W Karakawa; D A Young
Journal:  J Clin Microbiol       Date:  1979-03       Impact factor: 5.948

8.  Group A streptococcal peptidoglycan-polysaccharide inhibits phagocytic activity of human polymorphonuclear leukocytes.

Authors:  P A Leong; M S Cohen
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

9.  Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans.

Authors:  C P Timmerman; E Mattsson; L Martinez-Martinez; L De Graaf; J A Van Strijp; H A Verbrugh; J Verhoef; A Fleer
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

10.  Dichotomy between opsonization and serum complement activation by encapsulated staphylococci.

Authors:  P K Peterson; Y Kim; B J Wilkinson; D Schmeling; A F Michael; P G Quie
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.